Literature DB >> 20861016

Dimerization of Toll-like receptor 3 (TLR3) is required for ligand binding.

Yan Wang1, Lin Liu, David R Davies, David M Segal.   

Abstract

TLR3 (Toll-like receptor 3) recognizes dsRNA, a potent indicator of viral infection. The extracellular domain of TLR3 dimerizes when it binds dsRNA, and the crystal structure of the dimeric complex reveals three sites of interaction on each extracellular domain, two that bind dsRNA and one that is responsible for dimer formation. The goal of this study was to determine which amino acid residues are essential for forming a stable receptor·ligand complex and whether dimerization of TLR3 is required for dsRNA binding. Using a novel ELISA to analyze dsRNA binding by mutant TLR3 constructs, we identified the essential interacting residues and determined that the simultaneous interaction of all three sites is required for ligand binding. In addition, we show that TLR3 is unable to bind dsRNA when dimerization is prevented by mutating residues in the dimerization site or by immobilizing TLR3 at low density. We conclude that dimerization of TLR3 is essential for ligand binding and that the three TLR3 contact sites individually interact weakly with their binding partners but together form a high affinity receptor·ligand complex.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861016      PMCID: PMC2978612          DOI: 10.1074/jbc.M110.167973

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  The molecular structure of the Toll-like receptor 3 ligand-binding domain.

Authors:  Jessica K Bell; Istvan Botos; Pamela R Hall; Janine Askins; Joseph Shiloach; David M Segal; David R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

2.  Crystal structure of human toll-like receptor 3 (TLR3) ectodomain.

Authors:  Jungwoo Choe; Matthew S Kelker; Ian A Wilson
Journal:  Science       Date:  2005-06-16       Impact factor: 47.728

3.  Biochemical and functional analyses of the human Toll-like receptor 3 ectodomain.

Authors:  C T Ranjith-Kumar; William Miller; Jin Xiong; William K Russell; Roberta Lamb; Jonathan Santos; Karen E Duffy; Larissa Cleveland; Mary Park; Kanchan Bhardwaj; Zhaoxiang Wu; David H Russell; Robert T Sarisky; M Lamine Mbow; C Cheng Kao
Journal:  J Biol Chem       Date:  2007-01-05       Impact factor: 5.157

4.  The dsRNA binding site of human Toll-like receptor 3.

Authors:  Jessica K Bell; Janine Askins; Pamela R Hall; David R Davies; David M Segal
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-23       Impact factor: 11.205

5.  Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide.

Authors:  Mi Sun Jin; Sung Eun Kim; Jin Young Heo; Mi Eun Lee; Ho Min Kim; Sang-Gi Paik; Hayyoung Lee; Jie-Oh Lee
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

6.  The TLR3 signaling complex forms by cooperative receptor dimerization.

Authors:  Joshua N Leonard; Rodolfo Ghirlando; Janine Askins; Jessica K Bell; David H Margulies; David R Davies; David M Segal
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-02       Impact factor: 11.205

7.  Toll-like receptor 3 promotes cross-priming to virus-infected cells.

Authors:  Oliver Schulz; Sandra S Diebold; Margaret Chen; Tanja I Näslund; Martijn A Nolte; Lena Alexopoulou; Yasu-Taka Azuma; Richard A Flavell; Peter Liljeström; Caetano Reis e Sousa
Journal:  Nature       Date:  2005-02-13       Impact factor: 49.962

Review 8.  Membrane transport in the endocytic pathway.

Authors:  J Gruenberg; F R Maxfield
Journal:  Curr Opin Cell Biol       Date:  1995-08       Impact factor: 8.382

9.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

10.  Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer.

Authors:  Jin Young Kang; Xuehua Nan; Mi Sun Jin; Suk-Jun Youn; Young Hee Ryu; Shinjee Mah; Seung Hyun Han; Hayyoung Lee; Sang-Gi Paik; Jie-Oh Lee
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

View more
  32 in total

1.  Antimicrobial peptides inhibit polyinosinic-polycytidylic acid-induced immune responses.

Authors:  Maroof Hasan; Catarina Ruksznis; Yan Wang; Cynthia Anne Leifer
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

2.  NMR studies of hexaacylated endotoxin bound to wild-type and F126A mutant MD-2 and MD-2·TLR4 ectodomain complexes.

Authors:  Liping Yu; Rachel L Phillips; DeSheng Zhang; Athmane Teghanemt; Jerrold P Weiss; Theresa L Gioannini
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

Review 3.  Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses.

Authors:  Man Yu; Stewart J Levine
Journal:  Cytokine Growth Factor Rev       Date:  2011-04-03       Impact factor: 7.638

Review 4.  Structural aspects of nucleic acid-sensing Toll-like receptors.

Authors:  Umeharu Ohto; Toshiyuki Shimizu
Journal:  Biophys Rev       Date:  2016-02-12

Review 5.  TLR3 immunity to infection in mice and humans.

Authors:  Shen-Ying Zhang; Melina Herman; Michael J Ciancanelli; Rebeca Pérez de Diego; Vanessa Sancho-Shimizu; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2013-01-03       Impact factor: 7.486

6.  Consensus design of a NOD receptor leucine rich repeat domain with binding affinity for a muramyl dipeptide, a bacterial cell wall fragment.

Authors:  Rachael Parker; Ana Mercedes-Camacho; Tijana Z Grove
Journal:  Protein Sci       Date:  2014-04-17       Impact factor: 6.725

Review 7.  The structural biology of Toll-like receptors.

Authors:  Istvan Botos; David M Segal; David R Davies
Journal:  Structure       Date:  2011-04-13       Impact factor: 5.006

Review 8.  The effects of structure on pre-mRNA processing and stability.

Authors:  Rachel Soemedi; Kamil J Cygan; Christy L Rhine; David T Glidden; Allison J Taggart; Chien-Ling Lin; Alger M Fredericks; William G Fairbrother
Journal:  Methods       Date:  2017-06-06       Impact factor: 3.608

9.  Cardiomyocyte Maturation Requires TLR3 Activated Nuclear Factor Kappa B.

Authors:  Conrad P Hodgkinson; Richard E Pratt; Imke Kirste; Sophie Dal-Pra; John P Cooke; Victor J Dzau
Journal:  Stem Cells       Date:  2018-04-22       Impact factor: 6.277

10.  Structural insights into RNA recognition by RIG-I.

Authors:  Dahai Luo; Steve C Ding; Adriana Vela; Andrew Kohlway; Brett D Lindenbach; Anna Marie Pyle
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.